Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Buy
1,131
+138
+14% +$47.2K 0.07% 163
2026
Q1
$349K Buy
993
+56
+6% +$20K 0.08% 149
2025
Q4
$307K Buy
937
+154
+20% +$48.9K 0.07% 151
2025
Q3
$221K Sell
783
-13
-2% -$3.77K 0.06% 188
2025
Q2
$222K Buy
+796
New +$226K 0.07% 169

Other funds holding AMGN

EWA LLC's AMGN Position: Q2 2026 in Review

EWA LLC increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $47.2K and bringing the position to 1,131 shares worth $410K. The position accounts for 0.07% of the portfolio, ranked #163.

EWA LLC first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • EWA LLC held 1,131 shares of Amgen worth $410K as of Q2 2026.
  • EWA LLC bought 138 Amgen shares in Q2 2026, an estimated $47.2K.
  • Amgen made up 0.07% of EWA LLC's portfolio in Q2 2026, its #163 holding.
  • EWA LLC first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.